申请人:POLA CHEMICAL INDUSTRIES, INC.
公开号:EP0612738A1
公开(公告)日:1994-08-31
A diphenylpiperazine derivative represented by general formula (1), salt thereof, and drug for the circulatory organs containing the same as the active ingredient:
wherein R¹ and R² may be the same or different from each other and each represents hydrogen, halogen, alkyl, alkoxy, nitro, amino, hydroxy, optionally esterified carboxyl or trifluoromethyl; R³ represents hydrogen, alkyl, aralkyl, acyl, nitro or optionally esterified carboxymethyl; Ar represents phenyl or naphthyl which may have one to three substituents such as halogen, alkyl, alkoxy, aryloxy, aralkyloxy, nitro, amino, cyano, acyl, hydroxy, optionally esterified carboxyl, substituted sulfonyl, aryl or trifluoromethyl; Z represents sulfur or -NR⁴- wherein R⁴ represents hydrogen, alkyl, aralkyl, acyl, aryl, substituted sulfonyl or optionally esterified carboxyl; m represents a number of 1 to 5; and n represents a number of 0 to 5.
由通式(1)代表的二苯基哌嗪衍生物、其盐,以及以其为有效成分的循环器官用药:
其中 R¹ 和 R² 可以相同或互不相同,各自代表氢、卤素、烷基、烷氧基、硝基、氨基、羟基、任选酯化羧基或三氟甲基;R³ 代表氢、烷基、芳烷基、酰基、硝基或任选酯化羧甲基;Ar 代表苯基或萘基,可具有一至三个取代基,如卤素、烷基、烷氧基、芳氧基、芳烷氧基、硝基、氨基、氰基、酰基、羟基、任选酯化羧基、取代磺酰基、芳基或三氟甲基;Z 代表硫或-NR⁴-,其中 R⁴ 代表氢、烷基、芳烷基、酰基、芳基、取代的磺酰基或任选酯化的羧基;m 代表 1 至 5 的数字;以及 n 代表 0 至 5 的数字。